These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6235230)

  • 21. A comparison of the biological and biochemical properties of 1-(4-amino-2-methylpyrimidin-5-yl)methyl-3-(2-chloroethyl)-3-nitrosourea and 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose.
    Nagourney RA; Fox P; Schein PS
    Cancer Res; 1978 Jan; 38(1):65-8. PubMed ID: 145314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increasing DNA repair methyltransferase levels via bone marrow stem cell transduction rescues mice from the toxic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea, a chemotherapeutic alkylating agent.
    Maze R; Carney JP; Kelley MR; Glassner BJ; Williams DA; Samson L
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):206-10. PubMed ID: 8552605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacology of chlorozotocin Nsc-178248), a new nitrosourea antitumor agent.
    Schein PS; Panasci L; Woolley PV; Anderson T
    Cancer Treat Rep; 1976 Jun; 60(6):801-5. PubMed ID: 133756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticancer activity of new nitrosoureas against Walder carcinosarcoma 256 and DMBA-induced mammary cancer of the rat.
    Fiebig HH; Eisenbrand G; Zeller WJ; Zentgraf R
    Oncology; 1980; 37(3):177-83. PubMed ID: 6444708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular and molecular mechanisms of the bone marrow sparing effects of the glucose chloroethylnitrosourea chlorozotocin.
    Byrne P; Tew K; Jemionek J; MacVittie T; Erickson L; Schein P
    Blood; 1984 Apr; 63(4):759-67. PubMed ID: 6322885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. O6-methylguanine and temozolomide can reverse the resistance to chloroethylnitrosoureas of a mouse L1210 leukemia.
    D'Incalci M; Taverna P; Erba E; Filippeschi S; Potenza D; Mariani L; Citti L; Catapano CV
    Anticancer Res; 1991; 11(1):115-21. PubMed ID: 2018345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased mutagenicity of chloroethylnitrosoureas in the presence of a rat liver S9 microsome mixture.
    Suling WJ; Rice LS; Shannon WM
    J Natl Cancer Inst; 1983 Apr; 70(4):767-9. PubMed ID: 6220173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased survival and multilineage hematopoietic protection from delayed and severe myelosuppressive effects of a nitrosourea with recombinant interleukin-11.
    Maze R; Moritz T; Williams DA
    Cancer Res; 1994 Sep; 54(18):4947-51. PubMed ID: 8069861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pretreatment of normal human fibroblasts and human colon carcinoma cells with MNNG allows chloroethylnitrosourea to produce DNA interstrand crosslinks not observed in cells treated with chloroethylnitrosourea alone.
    Zlotogorski C; Erickson LC
    Carcinogenesis; 1983; 4(6):759-63. PubMed ID: 6861280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. More than additive toxicity of the combination of 1-methyl-1-nitrosourea plus 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat.
    Zeller WJ; Berger MR; Henne T; Weber E
    Cancer Res; 1986 Apr; 46(4 Pt 1):1714-6. PubMed ID: 3948161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of nitrosourea murine bone marrow toxicity with deoxyribonucleic acid alkylation and chromatin binding sites.
    Green D; Tew KD; Hisamatsu T; Schein PS
    Biochem Pharmacol; 1982 May; 31(9):1671-9. PubMed ID: 7104031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retroviral transfer of a bacterial alkyltransferase gene into murine bone marrow protects against chloroethylnitrosourea cytotoxicity.
    Harris LC; Marathi UK; Edwards CC; Houghton PJ; Srivastava DK; Vanin EF; Sorrentino BP; Brent TP
    Clin Cancer Res; 1995 Nov; 1(11):1359-68. PubMed ID: 9815932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selection for G156A O6-methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and protection from lethality in mice treated with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Davis BM; Reese JS; Koç ON; Lee K; Schupp JE; Gerson SL
    Cancer Res; 1997 Nov; 57(22):5093-9. PubMed ID: 9371508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of carbamoylation on cell survival and DNA repair in normal human embryo cells (IMR-90) treated with various 1-(2-chloroethyl)-1-nitrosoureas.
    Sariban E; Erickson LC; Kohn KW
    Cancer Res; 1984 Apr; 44(4):1352-7. PubMed ID: 6704956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. alpha-Difluoromethylornithine effects on nitrosourea-induced cytotoxicity and crosslinking in a methylation excision repair positive (MER+) human cell line.
    Ducore JM
    Biochem Pharmacol; 1987 Jul; 36(13):2169-74. PubMed ID: 3111477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of O6-benzylguanine on the anti-tumour activity and normal tissue toxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea and molecular combinations of 5-fluorouracil and 2-chloroethyl-1-nitrosourea in mice.
    Bibby MC; Thompson MJ; Rafferty JA; Margison GP; McElhinney RS
    Br J Cancer; 1999 Mar; 79(9-10):1332-9. PubMed ID: 10188873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo acute hematotoxicity of N,N'-bis[N-(2-chloroethyl)-N-nitrosocarbamoyl]cystamine (CNCC), a new nitrosourea analog.
    Blazsek I; Mathé G; Maral R; Jasmin C
    Toxicol Appl Pharmacol; 1984 Jun; 74(2):250-7. PubMed ID: 6740675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct reversal of DNA damage by mutant methyltransferase protein protects mice against dose-intensified chemotherapy and leads to in vivo selection of hematopoietic stem cells.
    Ragg S; Xu-Welliver M; Bailey J; D'Souza M; Cooper R; Chandra S; Seshadri R; Pegg AE; Williams DA
    Cancer Res; 2000 Sep; 60(18):5187-95. PubMed ID: 11016647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic evaluation of five nitrosoureas in a human melanoma xenograft system.
    Osieka R; Glatte P; Pannenbäcker R; Schmidt CG
    Cancer Chemother Pharmacol; 1983; 11(3):147-52. PubMed ID: 6227420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents.
    Neben S; Hellman S; Montgomery M; Ferrara J; Mauch P
    Exp Hematol; 1993 Jan; 21(1):156-62. PubMed ID: 8435103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.